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The federal government has a coordinated, risk-based system to ensure that new biotechnol-
ogy products are safe for the environment and for human and animal health. Established 
as a formal policy in 1986 (US-OSTP, 1986), the coordinated framework for regulation 
of biotechnology describes the federal system for evaluating products developed using 
modern biotechnology. The coordinated framework is based upon existing laws designed 
to protect public health and the environment. The US government has written new regula-
tions, policies, and guidance to apply these laws to biotechnology-derived products.
The US government agencies responsible for oversight of the products of modern 
agricultural biotechnology are the USDA’s Animal and Plant Health Inspection Service 
(USDA-APHIS), the US Environmental Protection Agency (EPA), and the Department 
of Health and Human Services’ Food and Drug Administration (FDA). Depending on 
its characteristics, a product may be subject to the jurisdiction of one or more of these 
agencies. Regulatory officials from the three agencies regularly communicate and exchange 
information to ensure that any safety or regulatory issues that may arise are appropriately 
resolved.
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Roles of US Regulatory Agencies
APHIS
Within USDA, APHIS is responsible for protecting agriculture from pests and diseases. 
Under the Plant Protection Act (7 USCC 104, 7701), USDA-APHIS has regulatory 
oversight over products of modern biotechnology that could pose a risk to plant or animal 
health. Accordingly, USDA-APHIS regulates organisms and products that are known or 
suspected to be plant pests or to pose a plant-pest risk, including those that have been 
altered or produced through genetic engineering. These are called “regulated articles.” 
USDA-APHIS regulates the import, handling, interstate movement, and release into the 
environment of regulated organisms that are products of biotechnology, including organ-
isms undergoing confined experimental use or field trials. Regulated articles are reviewed 
with regard to appropriate handling, confinement, and disposal to ensure that, under the 
proposed conditions of use, they do not present a plant-pest risk.
USDA-APHIS biotech regulations provide a petition process for the determination of 
nonregulated status. If a petition is granted, that organism will no longer be considered 
a regulated article and will no longer be subject to oversight by USDA-APHIS biotech 
regulations. The petitioner must supply information such as the biology of the recipient 
plant, experimental data and publications, genotypic and phenotypic descriptions of the 
genetically engineered organism, and field-test reports. The agency evaluates a variety 
of issues including the potential for plant-pest risk; disease and pest susceptibilities; the 
expression of gene products, new enzymes, or changes to plant metabolism; weediness 
and impact on sexually compatible plants; agricultural or cultivation practices; effects on 
non-target organisms; and the potential for gene transfer to other types of organisms. A 
notice is filed in the Federal Register and public comments are considered on the environ-
mental assessment and determination written for the decision on granting the petition. 
Copies of the USDA-APHIS documents are available to the public.
APHIS employs the term “biotechnology” to mean the use of recombinant-DNA tech-
nology, or genetic engineering (GE) to modify living organisms (7 CFR 340.1). APHIS 
regulates certain GE organisms that may pose a risk to plant or animal health.
FDA and EPA
FDA has primary responsibility for ensuring the safety of human food and animal feed, 
as well as proper labeling and safety of all plant-derived foods and feeds. EPA regulates 
pesticides, including plants with plant-incorporated protectants (pesticides intended to 
be produced and used in a living plant), to ensure public safety. That agency also regulates 
pesticide residue on food and animal feed. APHIS, through its Biotechnology Regulatory 
Services (BRS) program, regulates the introduction of certain GE organisms that may 
pose a risk to plant health.
APHIS Authority
Federal Statutes
Congress authorizes USDA agencies, including APHIS, to regulate specified areas of 
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US agriculture under federal statutes. The federal statute from which APHIS derives its 
authority to write regulations is the Plant Protection Act (7 USC, 7701). 
Federal Regulations
APHIS describes in their regulations what (importation, interstate movement and confined 
release) and how (time frames, permitting processes, penalties) certain GE organisms 
may be regulated. All formal federal regulations are published in the Federal Register and 
also in the Code of Federal Regulations (CFR). Regulations for agriculture and the USDA 
comprise fifteen volumes and those governing biotechnology as overseen by APHIS are 
found in Title 7 of the CFR part 340.
Regulatory Trigger Under Current 7 CFR 340.
Organisms that were created using recombinant-DNA techniques and are plant pests are 
regulated under the current version of 7 CFR 340. The definition of a plant pest found 
in the regulations (7 CFR 340.1) is:
Any living stage (including active and dormant forms) of insects, mites, nematodes, 
slugs, snails, protozoa, or other invertebrate animals, bacteria, fungi, other 
parasitic plants or reproductive parts thereof; viruses; or any organisms similar to 
or allied with any of the foregoing; or any infectious agents or substances, which 
can directly or indirectly injure or cause disease or damage in or to any plants or 
parts thereof, or any processed, manufactured, or other products of plants.
Organisms such as plants that are not normally considered to be plant pests also fall un-
der the regulation if they were engineered with DNA from a donor organism, recipient 
organism, vector, or vector agent that is listed as a plant pest in 7 CFR 340.2, such as 
Agrobacterium tumefaciens. If a GE organism meets the definition of a regulated article, 
APHIS authorization is required for its importation, interstate movement, or confined 
release into the environment.
Petition Process for a determination of Nonregulated Status
Engineered organisms that meet the definition of a regulated article represent a potential 
plant-pest risk until the agency determines that it does not pose a plant-pest risk. The 
petitioner is required to provide information under § 340.6(c)(4) related to plant-pest risk 
that the agency may use to determine whether the regulated article is unlikely to present a 
greater plant-pest risk than the unmodified organism. A GE organism is no longer subject 
to the regulatory requirements of 7 CFR part 340 or the plant-pest provisions of the Plant 
Protection Act when APHIS determines that it is unlikely to post a plant-pest risk.
Am I Regulated?
The current regulations under 7 CFR 340 do not apply to all GE organisms or even all 
GE plants. For example, plants transformed by particle bombardment with DNA that is 
not derived from a plant pest do not trigger the regulations under 7 CFR 340. APHIS 
may be consulted as to whether a specific organism falls under the regulation through a 
process named Am I regulated? APHIS’ response specifically addresses whether or not the 
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GE organism is regulated under 7CFR 340; however, APHIS does consider if other US 
agencies or other APHIS regulations are triggered and indicates such in the response as 
appropriate. The APHIS website lists the types of information that should be included 
in a letter of inquiry at the following link: Am I Regulated1?
Previous letters and responses are posted at the following link:
Regulated Letters of Inquiry2.
APHIS has made several decisions on whether GE plants are regulated under 7 CFR 
340. Cases where APHIS concluded that the engineered plants were not regulated under 
CFR 340 include:
• Null segregants from genetically engineered plants (6/6/2012; 10/27/12)
• Deletion of the IPK1 gene in maize using zinc finger nuclease (5/26/12)
• Targeted gene deletions using I-CreI meganuclease (1/6/12)
• Centromere-mediated chromosome elimination (10/27/11)
On two occasions, APHIS responded to letters of inquiry that DNA insertion or editing 
would be handled on a case by case basis:
• For zinc-finger nuclease (3/8/12)
• For I-CreI meganuclease (5/16/11).
Efforts to Revise 7 CFR 340
Beginning in 2004, APHIS began a process to thoroughly revise the regulations under 7 
CFR 340. Stakeholder scoping meetings were held in February and March of that year. In 
August 2007, a draft EIS was published and a public comment period was held (USDA-
APHIS, 2007). About 23,000 comments were received on the draft EIS (USDA-APHIS, 
2008). The proposed rule was published four years later, on October 9, 2008. Two meetings 
to discuss proposed regulations were held, in November 2008 and April 2009. 
APHIS has two options to close out the proposed rule. It can withdraw it or it can 
finalize it in whole or in part. Because APHIS is still in active rulemaking, APHIS is not 
1http://www.aphis.usda.gov/wps/portal/aphis/ourfocus/biotechnology/sa_regulations/!ut/p/a1/
rZLLcoIwFIafpksmEYSEpYjKRWqntlXYMCFySYsEIXaqT99Au7Ez3maa3Zl85_L_54AIrE-
FUkU-WE8F4RcoujozYWzjqwIKqO5tNLOg-TudPyPdUqOoSCE-ApTmRwNs0wHOk-R46zcfIg-
dCdLjzfspcatAdgBSIQ0UrUogAhqQvWxpRXIq1EXLKkIc3hAbYk5vsmzjjdt32UMC5SWlS85PnPf5Pm-7Ifuu0K1pRtQJgmEOl-
GoiumgTfKkGpEwYjoCtpQqGEzo6au_gqAZ94I3mvAKeDrt-WPZyNniOay4xCr0LUtx0ZmIL0yruX3Bl5ZQQ9cknixSaehBy-
4MGUoV6GwFCSzvXIt3g2_sfbeLRvJ8uoP5EmD9P_cjK6tNMA5yOTARhcKqjIP1H6jevm6xdmBM-Xh2ji_ZdoXbbzOWZ0U!/
?1dmy&urile=wcm%3apath%3a%2Faphis_content_library%2Fsa_our_focus%2Fsa_biotechnology%2Fsa_regulations%2Fct_am_i_reg
2http://www.aphis.usda.gov/wps/portal/aphis/ourfocus/biotechnology/sa_regulations/ct_am_i_reg/!ut/
p/a1/tVLLVoMwFPyWLlxykgbawBJKWx7FeqxaYMMJEUqUVyH1WL_egC5k0dfC7G4yk3tn7oAQ-
CAsyQfbEc6qkuRdHU4jZ22hsQGRvVzODWjfL1YP2HUQRBMBCAaAjTYXgJeFp66w7-
Dp4yFexBaG9WDuuYW5kaI7BFoQgpCWveQYCUmesjWhV8qTkUc7ihjTHO9iSqDo0UVrR-
Q9tXMat4QrOyyqvdz3uT7A55P7RAUB6RImLdZfd7TdkrCFIliRVMqaQpqiYpJIVSDGVFo-
imBcIJThMbTXzXwxNHhrW4MAe7kOv5sqVsKXomOioqgbRqWiTVPGDe9xO_dvLCPHnBO4tk-
mnYYecGbIQKjAJ38QgM2Na3Gu8I297fehLrLUpeeTA_8fwiTaoMabeSJWNeGZxMq0Av6QAfy_jL-
p4LlT5yJj0_mh9PaXFVm11fTT6BmBMwKo!/?1dmy&urile=wcm%3apath%3a%2Faphis_content_
library%2Fsa_our_focus%2Fsa_biotechnology%2Fsa_regulations%2Fct_reg_loi
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at liberty to discuss the ensuing agency deliberations that have occurred since April 2009. 
APHIS may discuss the fundamental revisions that were proposed in the rule in 2008.
Noxious-Weed Authority
When 7 CFR 340 was codified in 1987, it derived its authority from the Federal Plant 
Pest Act of 1957 (PL 85-36) and the Plant Quarantine Act of 1912 (7 USC 151), which 
provide APHIS authority to regulate plant pests. In 2000, the Federal Plant Pest Act and 
Plant Quarantine Act were subsumed into the Plant Protection Act (7 USC 7701). In 
addition, the PPA incorporates authority that previously was under the Noxious Weed Act 
of 1974 (PL 93-629), which gave APHIS additional authority to regulate noxious weeds. 
One of the most fundamental changes APHIS proposed for the new 7 CFR 340 was to 
include a provision for noxious-weed authority. As defined under the current regulations 
and the PPA, most plants are not plant pests, with the exception of a few parasitic species, 
such as striga, witchweed, and dodder. Hence the noxious-weed authority may be more 
appropriate for regulation of genetically engineered plants that may pose a weed risk.
Risk-Based Regulation/Regulatory Trigger.
As noted in the proposed rule (USDA-APHIS 2008 p. 60011):
[T]echnological advances have led to the possibility of developing GE organisms 
that do not fit within the plant pest definition, but may cause plant pest or weed 
damage covered by the definition of noxious weed in the PPA.
One objective of the proposed rule was to make the regulatory trigger consistent with 
current science and to provide regulatory oversight commensurate with the risk due to 
the organism. Under such a change, APHIS could conclude that organisms that were not 
previously regulated under the old 7 CFR 340 regulation might fall under the oversight 
of the new regulation. 
Reduced Regulatory Burden
Just as there is the possibility that organisms that do not fall under the current regula-
tions at 7 CFR 340 may cause plant-pest or weed damage covered by the definition of 
noxious weed in the PPA, there are many examples of organisms that do not cause such 
harm, but, nevertheless, are regulated under 7 CFR 340. The proposed rule sought to 
reduce regulatory burden by applying regulatory oversight commensurate with risk. For 
example, to quote the proposed rule (USDA-APHIS 2008 at p. 60012);
APHIS would subject a GE organism to regulatory oversight based upon known 
plant pest and noxious weed risks of the parent organisms, or based upon the traits 
of the GE organism, or based upon the possibility of unknown risks as a plant 
pest or noxious weed when insufficient information is available.
Principles for the Oversight of Emerging Technologies
Although APHIS is not in a position, as mentioned above, to discuss agency deliberations 
on the proposed rule until closeout, there is a relevant document that describes overarch-
ing principles for the regulation and oversight of the products of emerging technologies. 
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These principles are described in a memo by the White House Office of Science and 
Technology Policy (US-OSTP, 2011) that APHIS has been adhering to in its deliberations 
on the new 7 CFR 340. These principles are listed below:
• [T]o ensure the fulfillment of legitimate objectives such as of the protection of safety, 
health, and the environment while avoiding unjustifiably inhibiting innovation, 
stigmatizing new technologies, and creating trade barriers. … When no significant 
oversight issue based on a sufficiently distinguishing attribute of the technology or 
the relevant application can be identified, agencies should consider the option not to 
regulate.
• Scientific Integrity—Federal regulation and oversight of emerging technologies should 
be based on the best available scientific evidence. Adequate information should be 
sought and developed, and new knowledge should be taken into account when it be-
comes available. To the extent feasible, purely scientific judgments should be separated 
from judgments of policy. … Decisions should be based on the best reasonably obtain-
able scientific, technical, economic, and other information, within the boundaries of 
the authorities and mandates of each agency.
• Public Participation—To the extent feasible and subject to valid constraints (involv-
ing, for example, national security and confidential business information), relevant 
information should be developed with ample opportunities for stakeholder involvement 
and public participation. Public participation is important for promoting account-
ability, for improving decisions, for increasing trust, and for ensuring that officials 
have access to widely dispersed information.
• Communication—The Federal Government should actively communicate information 
to the public regarding the potential benefits and risks associated with new technolo-
gies.
• Benefits and Costs—Federal regulation and oversight of emerging technologies should 
be based on an awareness of the potential benefits and the potential costs of such 
regulation and oversight, including recognition of the role of limited information and 
risk in decision making. … The benefits of regulation should justify the costs (to the 
extent permitted by law and recognizing the relevance of uncertainty and the limits of 
quantification and monetary equivalents).
• Flexibility—To the extent practicable, Federal regulation and oversight should provide 
sufficient flexibility to accommodate new evidence and learning and to take into ac-
count the evolving nature of information related to emerging technologies and their 
applications.
• Risk Assessment and Risk Management—Risk assessment should be distinguished from 
risk management. The Federal Government should strive to reach an appropriate level 
of consistency in risk assessment and risk management across various agencies and 
offices and across various technologies. Federally mandated risk management actions 
should be appropriate to, and commensurate with, the degree of risk identified in an 
assessment.
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• Coordination—Federal agencies should seek to coordinate with one another, with state 
authorities, and with stakeholders to address the breadth of issues, including health 
and safety, economic, environmental, and ethical issues (where applicable) associated 
with the commercialization of an emerging technology, in an effort to craft a coherent 
approach. There should be a clear recognition of the statutory limitations of each 
Federal and state agency and an effort to defer to appropriate entities when attempting 
to address the breadth of issues.
In Conclusion
At the present time, APHIS considers products of emerging technologies under the current 
7 CFR 340. Organisms engineered without plant-pest sequences may not fall under the 7 
CFR 340 regulations. The Am I Regulated? process is specifically used to ascertain whether 
the agency concludes that the organism is regulated under 7 CFR 340 or whether other 
APHIS regulations are triggered. APHIS is still in active rule making having proposed 
changes to 7 CFR 340 such as including a noxious-weed provision, changing the regula-
tory trigger, implementing oversight commensurate with risk, and reducing regulatory 
burden. A revised 7 CFR 340 may fundamentally change the oversight of the products 
created with emerging technologies compared to the current regulations.  
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